10.1007/s10565-011-9198-2 10 CirinoG.SzaboC.PapapetropoulosA
Patients lost an average of 2 kg (4.4 lbs) more with a 5 mg dose, 4 kg (8.8 lbs) more with a 10 mg dose, and 6 kg (13.2 lbs) more with a 15 mg dose
Bailey, M, Tokheim, C, Porta-Pardo, E, Sengupta, S, Wang, Z, Liang, H, Liu, Y, Zhang, W, Akbani, R, Broom, BM, Ju, Z, Kanchi, RS, Korkut, A, Li, J, Ling, S, Liu, W, Lu, Y, Mills, GB, Uppore Kukkillaya, AR, Weinstein, JN, Zhang, J, Liu, X, Wang, L , Carvalho, AL, Fregnani, JG, Reis, RV, Scapulatempo, CN, Ajani, JA, Behrens, MC, Bondaruk, J, Broaddus, R, Czerniak, BA, Esmaeli, B, Fujimoto, J, Gershenwald, JE, Guo, CC, Lazar, A, Logothetis, CJ, Meric-Bernstam, F, Moran, C, Ramondetta, LM, Rice, DC, Sood, AK, Tamboli, P, Thompson, T, Troncoso, P, Tsao, A, Wistuba, II, von Deimling, A, Chen, K
They also activate NK cells, aiding in tumor suppression and immune balance (90), suggesting potential benefits for immune-related conditions such as thyroiditis and DM (29)
Research Areas Where the Combination Is Most Commonly Investigated In the scientific literature, the combination of BPC-157 and Thymosin Beta-4 is most frequently investigated in relation to: Skeletal muscle regeneration Tendon and ligament healing Skin repair Angiogenesis Vascular remodeling Cell migration Extracellular matrix organization Experimental models of soft tissue injury Most of the available evidence currently comes from laboratory studies and animal models
